Loading the section
Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 15, 2026 | 59.00 | 59.20 | 57.91 | 58.47 | 3m |
| September 14, 2026 | 58.66 | 59.55 | 57.75 | 59.05 | 3m |
| September 11, 2026 | 58.95 | 59.54 | 58.35 | 58.61 | 3m |
| September 10, 2026 | 60.45 | 60.71 |
Based on reports through December 31, 2025
Share count is a period average, so market cap is approximate.
Royalty Pharma buys the right to a share of sales of already-approved drugs — it researches and manufactures nothing.
A university or biotech that invented a drug receives royalties from whoever sells it. Royalty Pharma buys that future stream for a lump sum: the seller gets money today and sheds the risk, the buyer gets years of income without laboratories, factories or a sales force.
The portfolio is assembled so that no single drug decides the company's fate. The main risks lie elsewhere: patent expiry, which ends a stream on schedule, and competition for deals, which raises acquisition prices. Such a stock is better assessed as a portfolio of rights with known end dates than as a pharmaceutical company. Dividends are paid regularly.
Address:110 EAST 59TH STREET, NEW YORK, NY, 10022, US
| 1.2bn |
| PFEPfizer, Inc. | 27.66 | +0.71 % | 992m |
| ABTAbbott Laboratories | 102.56 | +19.50 % | 848m |
| VRTXVertex Pharmaceuticals Incorporated | 514.98 | +33.50 % | 582m |
| BMYBristol-Myers Squibb Company | 62.76 | −1.32 % | 575m |
| 58.64 |
| 58.75 |
| 3m |
| September 09, 2026 | 60.60 | 60.80 | 59.31 | 60.59 | 4m |
| September 08, 2026 | 59.21 | 60.86 | 58.63 | 60.59 | 9m |
| September 04, 2026 | 63.55 | 64.38 | 63.43 | 63.96 | 3m |
| September 03, 2026 | 63.57 | 63.94 | 62.50 | 63.88 | 3m |
| September 02, 2026 | 62.66 | 63.29 | 62.03 | 63.11 | 3m |
| September 01, 2026 | 61.82 | 62.58 | 61.61 | 62.32 | 3m |
| August 31, 2026 | 60.81 | 61.68 | 60.39 | 61.41 | 4m |
| August 28, 2026 | 61.92 | 62.01 | 60.66 | 60.85 | 2m |
| August 27, 2026 | 61.42 | 62.35 | 61.01 | 61.92 | 2m |
| August 26, 2026 | 62.04 | 62.28 | 61.49 | 61.80 | 1m |
| August 25, 2026 | 61.33 | 62.46 | 60.87 | 62.07 | 2m |
| August 24, 2026 | 61.19 | 61.54 | 60.80 | 61.33 | 2m |
| August 21, 2026 | 60.53 | 61.60 | 60.37 | 61.31 | 2m |
| August 20, 2026 | 61.33 | 62.13 | 60.37 | 60.58 | 3m |
| August 19, 2026 | 60.12 | 61.80 | 59.75 | 61.73 | 3m |
| August 18, 2026 | 59.74 | 60.42 | 59.66 | 59.69 | 2m |